~~<i id='21ADE77CFD'><strike id='21ADE77CFD'><tt id='21ADE77CFD'><pre id='21ADE77CFD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

explore

author：hotspot 2025-10-01 23:59:29 - browse：1

Allergan, Dom Smith/STAT

It wasn’t supposed to work out this way for Brent Saunders.

Four years ago, Saunders was the whiz kid of the pharmaceutical set. At 44, he had created a large pharmaceutical firm, then called Actavis, almost by force of will after engineering more than $100 billion in deals in a two-year span. Then he had swooped in to rescue Botox maker Allergan from the nefarious claws of Valeant Pharmaceuticals, an asset-stripping drug company loved by many on Wall Street but no one with a conscience.

As CEO, he paired his dealmaking with a boyish charm and a willingness to take on big issues that made him seem like a potential spokesman for the whole industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Health care court cases: Humana, Sutter, Novant

focus

entertainment

leisure time

focus

Wikipedia

AttendeesoftheWorldScoutJamboreepreparetoleaveascoutcampingsiteinBuan,SouthKorea,Tuesday,Aug.8,2023.

WSS

My daughter's legacy lives on through her writing, phage therapy

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

leisure time

explore

focus

Apple is now the first public company to be valued at $3 trillion

Statins may not be needed by millions of people, study suggests

Novavax promises a turnaround & Lilly roils the obesity market

'The Exorcist' director William Friedkin dead at 87

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Pharma companies must ensure equitable access to obesity drugs

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biden will tout long

In age of alternative facts, a scholarly course on calling out crap

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

focus

ALS patient reclaims some autonomy thanks to wearable 'robot'

At least 12 people were injured in a blast at a port in northwest Turkey

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Stephen Quake on the Chan Zuckerberg quest to conquer disease

In medicine, common shorthands can shortchange care

Illinois to ban advertising for guns allegedly marketed to kids and militants

entertainment

leisure time

focus

Wikipedia